The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer

Abstract CINSARC, a multigene expression signature originally developed in sarcomas, was shown to have prognostic impact in various cancers. We tested the prognostic value for disease-free survival (DFS) of CINSARC in a series of 6035 early-stage invasive primary breast cancers. CINSARC had independ...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Anthony Goncalves, Pascal Finetti, Daniel Birnbaum, François Bertucci
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
Accès en ligne:https://doaj.org/article/ecafbdc5cfd6482fbd26fa13182d387e
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!